GENOWAYACT. Aktie
| 2,64EUR | -0,01EUR | -0,38% |
WKN DE: A0MRJ4 / ISIN: FR0004053510
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 125 | 131 | 133 | 143 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,11 | 0,13 | 0,15 | 0,15 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 15 | 19 | 20 | 18 | 17 |
| Summe Anlagevermögen | 13 | 13 | 13 | 14 | 14 |
| Summe Aktiva | 27 | 32 | 33 | 32 | 32 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 20 | 19 | 19 | 16 | 14 |
| Summe Eigenkapital | 8 | 13 | 14 | 15 | 17 |
| Summe Passiva | 27 | 32 | 33 | 32 | 32 |
Adresse
| 31, Rue Saint Jean de Dieu, 69007 Lyon | |
| Telefon | +33 (4) 22-12-31-25 |
| Internet | http://www.genoway.com |
Management
|
Alexandre Fraichard
Director & General Manager |
|
Andre Tartar
Director |
|
Benjamin Bruneau
Chief Financial Officer |
|
Christian Grenier
Chairman & Chief Executive Officer |
|
Jean-Louis Menard
Director |
|
Laurent Fraisse
Director |
|
Olivier Antoine M. Charmeil
Director |
|
Patrick Blain
Director |
|
Raffy Kazandjian
Director |